Journal article
B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia
Proceedings of the National Academy of Sciences - PNAS, Vol.107(44), pp.18956-18960
11/02/2010
DOI: 10.1073/pnas.1013420107
PMCID: PMC2973856
PMID: 20956327
Abstract
Mice bearing a v-Myc myelocytomatosis viral oncogene homolog (c-Myc) transgene controlled by an Ig-alpha heavy-chain enhancer (iMycCα mice) rarely develop lymphomas but instead have increased rates of memory B-cell turnover and impaired antibody responses to antigen. We found that male progeny of iMycCα mice mated with mice transgenic (Tg) for CD257 (B-cell activating factor, BAFF) developed CD5+ B-cell leukemia resembling human chronic lymphocytic leukemia (CLL), which also displays a male gender bias. Surprisingly, leukemic cells of Myc/Baff Tg mice expressed higher levels of c-Myc than did B cells of iMycCα mice. We found that CLL cells of many patients with progressive disease also expressed high amounts of c-MYC, particularly CLL cells whose survival depends on nurse-like cells (NLC), which express high-levels of BAFF. We find that BAFF could enhance CLL-cell expression of c-MYC via activation the canonical IκB kinase (IKK)/NF-κB pathway. Inhibition of the IKK/NF-κB pathway in mouse or human leukemia cells blocked the capacity of BAFF to induce c-MYC or promote leukemia-cell survival and significantly impaired disease progression in Myc/Baff Tg mice. This study reveals an important relationship between BAFF and c-MYC in CLL which may affect disease development and progression, and suggests that inhibitors of the canonical NF-κB pathway may be effective in treatment of patients with this disease.
Details
- Title: Subtitle
- B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia
- Creators
- Weizhou Zhang - Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine andArnon P Kater - Department of HematologyGeorge F Widhopf - Departments ofHan-Yu Chuang - Departments ofThomas Enzler - Department of MedicineDanelle F James - Departments ofMaxim Poustovoitov - Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine andPing-Hui Tseng - Institute of Biochemistry and Molecular BiologySiegfried Janz - Department of PathologyCarl Hoh - Radiology, Moores Cancer CenterHarvey Herschman - Departments ofMichael Karin - Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine andThomas J Kipps - Departments of
- Resource Type
- Journal article
- Publication Details
- Proceedings of the National Academy of Sciences - PNAS, Vol.107(44), pp.18956-18960
- DOI
- 10.1073/pnas.1013420107
- PMID
- 20956327
- PMCID
- PMC2973856
- NLM abbreviation
- Proc Natl Acad Sci U S A
- ISSN
- 0027-8424
- eISSN
- 1091-6490
- Publisher
- National Academy of Sciences
- Language
- English
- Date published
- 11/02/2010
- Academic Unit
- Pathology; Radiation Oncology
- Record Identifier
- 9984083874902771
Metrics
24 Record Views